Nuvectra™ Announces Pricing of Follow-On Stock Offering

Medical Device Investing

Nuvectra (NASDAQ:NVTR), a neurostimulation medical device company, announced today the pricing of its underwritten follow-on public offering of 2,825,000 shares of its common stock at a price to the public of $8.00 per share. As quoted in the press release: The offering is expected to close on or about February 5, 2018, subject to customary closing …

As quoted in the press release:

The offering is expected to close on or about February 5, 2018, subject to customary closing conditions. In addition, Nuvectra has granted the underwriters a 30-day option to purchase up to 423,750 additional shares of common stock on the same terms and conditions.
Piper Jaffray is acting as sole book-running manager for the offering. JMP Securities and SunTrust Robinson Humphrey are acting as co-managers.

Click here to read the full press release.

medical device company neurostimulation nuvectra public offering suntrust robinson humphrey Medical Device Investing